Medico Remedies Limited (NSE:MEDICO)
 49.10
 -0.37 (-0.75%)
  Nov 4, 2025, 2:30 PM IST
Medico Remedies Revenue
Medico Remedies had revenue of 382.52M INR in the quarter ending June 30, 2025, with 24.20% growth. This brings the company's revenue in the last twelve months to 1.58B, up 9.81% year-over-year. In the fiscal year ending March 31, 2025, Medico Remedies had annual revenue of 1.51B with 4.15% growth.
Revenue (ttm) 
 1.58B
Revenue Growth 
 +9.81%
P/S Ratio 
 2.62
Revenue / Employee 
 7.44M
Employees 
 213
Market Cap 
4.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Mar 31, 2025 | 1.51B | 60.20M | 4.15% | 
| Mar 31, 2024 | 1.45B | 44.83M | 3.19% | 
| Mar 31, 2023 | 1.40B | 194.16M | 16.04% | 
| Mar 31, 2022 | 1.21B | -13.69M | -1.12% | 
| Mar 31, 2021 | 1.22B | 337.54M | 38.08% | 
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Sun Pharmaceutical Industries | 537.77B | 
| Aurobindo Pharma | 320.25B | 
| Cipla | 279.66B | 
| Zydus Lifesciences | 236.08B | 
| Apollo Hospitals Enterprise | 225.51B | 
| Glenmark Pharmaceuticals | 134.56B | 
| Alkem Laboratories | 133.04B | 
| Mankind Pharma | 129.10B | 
Medico Remedies News
- 4 weeks ago - Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government - Business Upturn